Cite
The Oxidative Drug Combination for Suppressing KRAS G12D Inducible Tumour Growth.
MLA
Begimbetova, Dinara, et al. “The Oxidative Drug Combination for Suppressing KRAS G12D Inducible Tumour Growth.” BioMed Research International, vol. 2022, Dec. 2022, pp. 1–14. EBSCOhost, https://doi.org/10.1155/2022/9426623.
APA
Begimbetova, D., Kukanova, A., Fazyl, F., Manekenova, K., Omarov, T., Burska, A. N., Khamijan, M., Gulyayev, A., Yermekbayeva, B., Makishev, A., Saliev, T., Batyrbekov, K., Aitbayev, C., Spatayev, Z., & Sarbassov, D. (2022). The Oxidative Drug Combination for Suppressing KRAS G12D Inducible Tumour Growth. BioMed Research International, 2022, 1–14. https://doi.org/10.1155/2022/9426623
Chicago
Begimbetova, Dinara, Assiya Kukanova, Fatima Fazyl, Kenzhekyz Manekenova, Talgat Omarov, Agata N. Burska, Medina Khamijan, et al. 2022. “The Oxidative Drug Combination for Suppressing KRAS G12D Inducible Tumour Growth.” BioMed Research International 2022 (December): 1–14. doi:10.1155/2022/9426623.